Healthcare · Healthcare

Dr. Lal Path Labs Ltd.

LALPATHLAB

NSE: LALPATHLAB

Key metrics

Market Cap

—

P/E Ratio

—

P/B Ratio

—

ROE

ROCE

6.07%

Debt / Equity

0.5x

Net Margin

Dividend Yield

—

EPS

₹3.57

Period

FY2024

Shareholding pattern

As of Q4FY2024

Promoter: 30.00%FII: 21.00%DII: 21.00%Public: 28.00%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→

Educational content — not investment adviceThis page presents publicly available information about Dr. Lal Path Labs Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.